Free Trial
OTCMKTS:DTCFF

Defence Therapeutics (DTCFF) Stock Price, News & Analysis

Defence Therapeutics logo
$0.76 0.00 (0.00%)
As of 05/28/2025

About Defence Therapeutics Stock (OTCMKTS:DTCFF)

Key Stats

Today's Range
$0.76
$0.76
50-Day Range
$0.62
$1.00
52-Week Range
$0.27
$1.16
Volume
N/A
Average Volume
17,215 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Defence Therapeutics Inc. engages in development of a biological drug enhancer platform that improves the efficacy and safety of a multitude of biological/biosimilar based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on development of vaccine for infectious disease and virus utilizing the ACCUMTM platform for drug delivery and effective treatments. The company was formerly known as Accum Therapeutics Inc. and changed its name to Defence Therapeutics Inc. in March 2020. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.

Receive DTCFF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Defence Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

DTCFF Stock News Headlines

Defence Therapeutics Inc.
Defence Therapeutics Inc (DTC.DU)
This document could hand you a shot at $915 every single weekend!
Something fascinating happens in the options market when most traders aren't paying attention… While everyone else collects standard daily premiums Monday through Friday... There's a special opportunity to target TRIPLE premiums just for holding positions over the weekend. Think about that... Most traders get one day's worth of premium for their trades. But by entering right before the weekend, when everything works out, you could collect THREE days worth - even though markets are closed for two of them. Thanks to a special discovery by a Wall Street legend who helped manage a $1.7 trillion firm – regular folks like you can now target extra cash from the markets on weekends… Just like he showed his small group of traders on December 20th with KO... A quick 2-minute setup Friday afternoon… Head out for the weekend... Monday morning? An extra $1,111 sitting in the account (with a $5k starting stake).
Defence Therapeutics Strengthens Leadership with Key Appointments
Defence Therapeutics to License Accum Technology
Defence Therapeutics Welcomes Radiopharmaceutical Expert
See More Headlines

DTCFF Stock Analysis - Frequently Asked Questions

Defence Therapeutics' stock was trading at $0.3901 at the beginning of 2025. Since then, DTCFF stock has increased by 94.2% and is now trading at $0.7578.
View the best growth stocks for 2025 here
.

Shares of DTCFF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:DTCFF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

This page (OTCMKTS:DTCFF) was last updated on 5/29/2025 by MarketBeat.com Staff
From Our Partners